Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer

BACKGROUND AND PURPOSE: Treatment of intermediate and high-risk prostate cancer with a high BED has been shown to increase recurrence free survival (RFS). While high dose rate (HDR) brachytherapy, given as a boost is effective in delivering a high BED, many patients are not candidates for the proced...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Anwar, Mekhail, Weinberg, Vivian, Seymour, Zachary, Hsu, I. Joe, Roach, Mack, Gottschalk, Alex R.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4721063/
https://ncbi.nlm.nih.gov/pubmed/26792201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0585-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados